摘要
目的:探讨依替米星治疗细菌感染的有效性和安全性。方法:按照系统评价的要求全面检索了Medline、中国数字医院图书馆中国生物医学文献光盘数据库,对符合纳入标准的文献进行Meta分析。结果:依替米星组与进口奈替米星组临床有效率、细菌清除率和不良反应发生率没有统计学差异。结论:依替米星治疗细菌感染疗效确切、使用安全。
Objective: To estimate the efficacy and safety of etimicin versus import netilmicin on bacterial infection. Method: According to the requirements of Cochrane systematic review,a thorough literature search was performed among Medline, Chinese digital Hospital Library and Chinese Biomedical Literature Disk Database. Meta-analysis was performed the literature which was acorded with the criterion. Result: Etimicin treatment group versus import netilmicin treatment group of clinical effective rates, bacterial eradication rates and adverse reaction rates had no statistic difference. Conclusion: Etimicin is effective and safe in the treatment of bacterial infections.
出处
《中国药师》
CAS
2007年第4期330-332,共3页
China Pharmacist